ARID5A and central nervous system cancer: These results suggest that ARID5A may affect the occurrence, development and clinical prognosis of glioma by regulating the above-mentioned pathways of glioma patients, and a high level of ARID5A expression is associated with the regulation of cell apoptosis and immune response in glioma.